EP1673389A2 - Varianten des cd40l-proteins - Google Patents
Varianten des cd40l-proteinsInfo
- Publication number
- EP1673389A2 EP1673389A2 EP04794935A EP04794935A EP1673389A2 EP 1673389 A2 EP1673389 A2 EP 1673389A2 EP 04794935 A EP04794935 A EP 04794935A EP 04794935 A EP04794935 A EP 04794935A EP 1673389 A2 EP1673389 A2 EP 1673389A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- group
- cd40l
- amino acid
- variant
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51043003P | 2003-10-10 | 2003-10-10 | |
US51772803P | 2003-11-05 | 2003-11-05 | |
US52354503P | 2003-11-20 | 2003-11-20 | |
PCT/US2004/033707 WO2005035570A2 (en) | 2003-10-10 | 2004-10-12 | Variants of cd40l protein |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1673389A2 true EP1673389A2 (de) | 2006-06-28 |
Family
ID=34437673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04794935A Withdrawn EP1673389A2 (de) | 2003-10-10 | 2004-10-12 | Varianten des cd40l-proteins |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1673389A2 (de) |
WO (1) | WO2005035570A2 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7381792B2 (en) | 2002-01-04 | 2008-06-03 | Xencor, Inc. | Variants of RANKL protein |
JP2005530482A (ja) | 2002-01-04 | 2005-10-13 | ゼンコー・インコーポレイテッド | ドミナントネガティブタンパク質およびそれらの用法 |
US7553930B2 (en) | 2003-01-06 | 2009-06-30 | Xencor, Inc. | BAFF variants and methods thereof |
WO2005113598A2 (en) * | 2004-05-21 | 2005-12-01 | Xencor, Inc. | Tnf super family members with altered immunogenicity |
WO2007054658A1 (en) * | 2005-11-14 | 2007-05-18 | King's College London | Control of immune responses |
EP2517723B1 (de) | 2006-09-18 | 2019-11-06 | The Board of Trustees of The University of Arkansas | Zusammensetzungen und Verfahren zur Verstärkung von Immunreaktionen |
US20100150931A1 (en) * | 2006-11-22 | 2010-06-17 | Centre Hospitalier De L'universite De Montreal | Novel receptor for cd40l and uses thereof |
BRPI0818736A2 (pt) | 2007-10-30 | 2017-06-13 | Univ Arkansas | composições e métodos para intensificar imunorrepostas à bactéria flagelada |
HUE047164T2 (hu) | 2007-11-01 | 2020-04-28 | Univ Arkansas | Kompozíciók és eljárások eimeria elleni immunválasz fokozására |
CA2730316A1 (en) | 2008-07-11 | 2010-01-14 | Phylogica Limited | Peptide inhibitors of cd40l signaling and uses therefor |
EP2525817B8 (de) | 2010-01-21 | 2017-09-20 | The Board of Trustees of The University of Arkansas | Impfstoffvektoren und verfahren zur verstärkung von immunreaktionen |
HUE046858T2 (hu) | 2010-06-09 | 2020-03-30 | Univ Arkansas | Vakcina és eljárások campylobacter fertõzés csökkentésére |
MY173328A (en) | 2013-02-14 | 2020-01-16 | Texas A & M Univ Sys | Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection |
EA033538B1 (ru) | 2013-03-15 | 2019-10-31 | Univ Arkansas | Композиции и способы усиления иммунного ответа на кишечные патогены |
TWI758288B (zh) | 2016-05-03 | 2022-03-21 | 阿肯色州大學董事會 | 包含免疫刺激性及抗原性多肽的酵母菌疫苗載體以及其使用方法 |
AU2018288863A1 (en) | 2017-06-22 | 2020-01-30 | Board Of Regents, The University Of Texas System | Methods for producing regulatory immune cells and uses thereof |
US20200390815A1 (en) | 2018-02-21 | 2020-12-17 | Board Of Regents, The University Of Texas System | Universal antigen presenting cells and uses thereof |
AU2020272944A1 (en) * | 2019-04-12 | 2021-11-25 | Board Of Regents, The University Of Texas System | Methods for producing regulatory B cells and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69631331T2 (de) * | 1995-06-07 | 2004-11-18 | Immunex Corp., Seattle | Cd40l mutein |
AU8867501A (en) * | 2000-09-01 | 2002-03-13 | Biogen Inc | Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
EP1390076A4 (de) * | 2001-04-27 | 2004-12-15 | Xcyte Therapies Inc | Reifung antigen-präsentierender zellen mit aktivierten zellen |
-
2004
- 2004-10-12 EP EP04794935A patent/EP1673389A2/de not_active Withdrawn
- 2004-10-12 WO PCT/US2004/033707 patent/WO2005035570A2/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO2005035570A3 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005035570A2 (en) | 2005-04-21 |
WO2005035570A3 (en) | 2005-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1673389A2 (de) | Varianten des cd40l-proteins | |
AU2004262014B2 (en) | Crystalline tumor necrosis factor receptor 2 polypeptides | |
Patel et al. | Engineering an APRIL-specific B cell maturation antigen | |
US7399829B2 (en) | Variants of RANKL protein | |
JP2008505607A (ja) | Bcmaの細胞外ドメインの変異体とその使用法 | |
WO2005113598A2 (en) | Tnf super family members with altered immunogenicity | |
US20050181994A1 (en) | Novel variants of CD40L protein | |
US20090155843A1 (en) | Tnf antagonists | |
WO2004081043A2 (en) | Baff mutants with at least one amino acid substitution and methods of their production | |
WO2006034106A2 (en) | Baff variants and methods therof | |
US20080044376A1 (en) | Cytokine Design | |
KR20100135706A (ko) | 가용성 종양 괴사 인자 수용체 돌연변이 | |
US7553930B2 (en) | BAFF variants and methods thereof | |
WO2004089982A2 (en) | April variants and methods thereof | |
WO2003059281A2 (en) | Novel variants of rankl protein | |
US7381792B2 (en) | Variants of RANKL protein | |
US20050003480A1 (en) | April variants and methods thereof | |
US20050221443A1 (en) | Tumor necrosis factor super family agonists | |
US20060228330A1 (en) | Dominant negative proteins and methods thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060504 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20070207 |